Literature DB >> 17654070

Globin chain synthesis is a useful complementary tool in the differential diagnosis of thalassemias.

Shohreh Khatami1, Soghra Rouhi Dehboneh, Sedigheh Sadeghi, Roghieh Mirzazadeh, Parinaz Saeedi, Parastoo Bayat, Hossein Najmabadi, Sirous Zeinali, Mohammad Taghi Akbari, Mohammad Ardjmand, Aref Amirkhani.   

Abstract

The present study aimed at differentiating rare types of heterozygous beta-thalassemia (thal) with normal Hb A(2) values from alpha-thal in Iranian carriers by globin chain synthesis in addition to other hematological parameters. Our study groups consisted of 51 normal subjects, 24 heterozygous beta- thalassemic subjects with high Hb A(2), 62 alpha-thal-2 subjects, 34 alpha-thal-1 subjects, six Hb H disease thalassemic subjects, 14 silent beta-thal subjects with normal Hb A(2) values, five deltabeta-thal subjects and two subjects with an association of alpha- and deltabeta-thal (total = 198). Analysis of globin chains was performed by high performance liquid chromatography (HPLC). The results showed that the alpha/beta ratio averages were close to the ones in the published literature, but with a greater standard deviation and a wider range. Globin chain synthesis (GCS) could be valuable in differentiating between microcytosis produced by silent beta-thal (heterozygous beta-thal with a normal Hb A(2) level) and that caused by alpha-thal. Since the complex genotype/phenotype relationship can lead to diagnostic difficulties, GCS cannot be used as the only diagnostic tool for thalassemia carrier detection. Therefore, a combination of different tests for each patient is required.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17654070     DOI: 10.1080/03630260701462006

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  1 in total

1.  Correlation between Plasma Interleukin-3, the α/β Globin Ratio, and Globin mRNA Stability.

Authors:  S Rouhi Dehnabeh; R Mahdian; S Ajdary; E Mostafavi; S Khatami
Journal:  Anemia       Date:  2014-11-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.